全文获取类型
收费全文 | 273篇 |
免费 | 1篇 |
国内免费 | 1篇 |
专业分类
儿科学 | 6篇 |
妇产科学 | 111篇 |
基础医学 | 10篇 |
口腔科学 | 2篇 |
临床医学 | 21篇 |
内科学 | 3篇 |
皮肤病学 | 1篇 |
神经病学 | 2篇 |
特种医学 | 5篇 |
外科学 | 8篇 |
综合类 | 50篇 |
预防医学 | 28篇 |
药学 | 18篇 |
中国医学 | 5篇 |
肿瘤学 | 5篇 |
出版年
2024年 | 1篇 |
2022年 | 5篇 |
2021年 | 1篇 |
2020年 | 2篇 |
2019年 | 24篇 |
2018年 | 15篇 |
2017年 | 2篇 |
2016年 | 2篇 |
2015年 | 6篇 |
2014年 | 20篇 |
2013年 | 23篇 |
2012年 | 13篇 |
2011年 | 11篇 |
2010年 | 7篇 |
2009年 | 8篇 |
2008年 | 6篇 |
2007年 | 11篇 |
2006年 | 7篇 |
2005年 | 5篇 |
2004年 | 4篇 |
2002年 | 1篇 |
2001年 | 1篇 |
2000年 | 1篇 |
1998年 | 2篇 |
1997年 | 1篇 |
1993年 | 1篇 |
1992年 | 1篇 |
1985年 | 4篇 |
1984年 | 25篇 |
1983年 | 2篇 |
1982年 | 9篇 |
1981年 | 9篇 |
1980年 | 9篇 |
1979年 | 5篇 |
1978年 | 8篇 |
1977年 | 8篇 |
1976年 | 5篇 |
1975年 | 5篇 |
1974年 | 4篇 |
1973年 | 1篇 |
排序方式: 共有275条查询结果,搜索用时 15 毫秒
271.
William McLeod James Brien Lesley Carmichael Carol Probert Nancy Steenaart John Patrick 《American journal of obstetrics and gynecology》1984,148(5):634-639
In order to determine whether intravenous injections of glucose could reserve the effects of maternal ingestion of ethanol (0.25 gm/kg), glucose (25 gm intravenously) or an equal volume of saline solution was administered to eight pregnant women at 37 to 40 weeks' gestation after ingestion of ethanol. Fetal breathing movements were abolished within 30 minutes after ingestion of ethanol and were not increased by maternal intravenous injections of glucose. Maternal heart rate was increased by ethanol. The disposition of ethanol in maternal blood was not altered by injection of glucose, and fetal gross body movements were not influenced by maternal ingestion of ethanol or by injections of glucose after ethanol. 相似文献
272.
Peter Collins Guiseppe Rosano Catherine Casey Caroline Daly Marco Gambacciani Peyman Hadji Risto Kaaja Tomi Mikkola Santiago Palacios Richard Preston Tabassome Simon John Stevenson Marco Stramba-Badiale 《European heart journal》2007,28(16):2028-2040
Cardiovascular risk is poorly managed in women, especially during the menopausal transition when susceptibility to cardiovascular events increases. Clear gender differences exist in the epidemiology, symptoms, diagnosis, progression, prognosis, and management of cardiovascular risk. Key risk factors that need to be controlled in the peri-menopausal woman are hypertension, dyslipidaemia, obesity, and other components of the metabolic syndrome, with the avoidance and careful control of diabetes. Hypertension is a particularly powerful risk factor and lowering of blood pressure is pivotal. Hormone replacement therapy is acknowledged as the gold standard for the alleviation of the distressing vasomotor symptoms of the menopause, but the findings of the Women's Health Initiative (WHI) study generated concern for the detrimental effect on cardiovascular events. Thus, hormone replacement therapy cannot be recommended for the prevention of cardiovascular disease. Whether the findings of WHI in older post-menopausal women can be applied to younger peri-menopausal women is unknown. It is increasingly recognized that hormone therapy is inappropriate for older post-menopausal women no longer displaying menopausal symptoms. Both gynaecologists and cardiovascular physicians have an important role to play in identifying peri-menopausal women at risk of cardiovascular morbidity and mortality and should work as a team to identify and manage risk factors such as hypertension. 相似文献
273.
274.
275.
van der Houwen C Boor K Essed GG Boendermaker PM Scherpbier AA Scheele F 《European journal of obstetrics, gynecology, and reproductive biology》2011,154(1):90-95